Pennsylvania-based Teleflex has further bet on the future of the urology market by agreeing to acquire Palette Life Sciences in a $600m cash upfront deal.
“Teleflex is focused on deploying capital for innovative products and technologies that can meaningfully enhance clinical efficacy, patient safety and comfort, reduce complications, and lower the overall cost of care,”...
Key Takeaways
-
Teleflex will pay $600m upfront to acquire Palette Life Sciences.
-
Palette's portfolio of urology devices complements...